Filing Details

Accession Number:
0001209191-21-014944
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-26 18:12:16
Reporting Period:
2021-02-24
Accepted Time:
2021-02-26 18:12:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512985 A. Michael Desjardin C/o Horizon Therapeutics Plc,
Connaught House 1St Fl, 1 Burlington Rd
Dublin L2 4
Evp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2021-02-24 10,786 $95.00 92,504 No 4 S Direct
Ordinary Shares Disposition 2021-02-24 5,158 $87.20 87,346 No 4 S Direct
Ordinary Shares Disposition 2021-02-26 1,099 $91.83 86,247 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.